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The association of adverse health with high fat intake has long been recognized. However, the lack of research
focusing on the interrelationship of thyroid and liver function, and the pathogenesis of a high fat diet leaves these
topics poorly understood. The objective of this study was to evaluate and compare the physiological changes in
euthyroid and thyroid altered animal model fed saturated and unsaturated high fat diets. To achieve this objective
adult male Sprague Dawley rats (n = 100) were fed one of five diets; a control or one of four test diets containing
25% saturated or unsaturated, and 37% saturated or unsaturated fats for a period of eight weeks. Each experimental
group consisted of ten euthyroid and ten thyroid altered animals. An altered thyroid state was chemically induced
with the addition of 0.05% propylthiouracil (PTU) in the drinking water. Euthyroid animals fed high fat diets
increased in body weights and body lengths, compared to thyroid altered animals (P < 0.05). Alanine
aminotransferase (ALT) and asparte aminotransferase (AST) levels increased across all experimental groups. HbA1C
values and urinary glucose values were within normal range for all animals. Liver morphology showed increased
hepatic stellate (ito) and vacuole cells in thyroid altered animals. These findings suggest that altered thyroid status
negatively impacts growth and weight gain, and simultaneously affected lipid metabolism, resulting in abnormal
liver morphology.
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Dietary fat plays a major role in human nutrition and
serves many essential functions. It is necessary to facili-
tate absorption of fat-soluble vitamins (A, D, E and K)
and carotenoids; provides insulation that prevents heat
loss, and protects vital organs from shock during normal
activities [1]. Diets with adequate energy (30% originat-
ing from fat) are sufficient to promote normal growth
and normal sexual maturation; conversely, diets that ex-
ceed this amount may result in excessive weight gain [2].
Dietary fat intake and excessive caloric intake has been
proposed as a causative factor in the development of
metabolic syndrome. In this regard, the quantity as well
as the quality (primarily) of dietary fat consumed
strongly predicts the prevalence and possibility of insulin
resistance, type 2 diabetes and atherosclerosis [3,4]. In
addition, a high fat diet lowers glucose uptake and* Correspondence: ndawkins@mytu.tuskegee.edu
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distribution, and reproduction in any mediuminadequately suppresses hepatic glucose production
stimulated by insulin [5,6]. High-fat diets have been
reported to impair glucose metabolism in rat skeletal
muscle, which is the major site of insulin-stimulated glu-
cose metabolism [7]. In the U.S. food prepared away
from home is higher in total energy, total fat, saturated
fat, cholesterol and sodium, and contains less fiber and
calcium and is overall of poorer nutritional quality than
food prepared at home. Also, the fat content of at-home
food has fallen considerably from 41% of total energy in
1977 to 31.5%, but there has been no change in the fat
content of food prepared away from home which re-
mains approximately 37.6% [8]. Higher than necessary
energy intake has also been shown to cause whole body
and skeletal muscle insulin resistance, hyperinsulinemia,
hyperglycemia and, if perpetuated over an extended
period of time, could lead to the development of dia-
betes [7]. Research shows that the fatty acid composition
in TGs mainly affects the development of obesity, dia-
betes and hyperlipidemia [9]. Excessive saturated fat
(SFA) consumption promotes lipid storage andentral Ltd. This is an Open Access article distributed under the terms of the
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play a protective role by controlling the synthesis and
oxidation of SFA. Furthermore, monounsaturated fatty
acids (MUFAs) lower hepatic fat content, and improve
blood lipid profiles associated with risk of cardiovascular
disease [10]. Additionally, dietary fat has also been asso-
ciated with endocrine and metabolic changes [5,6]; the
liver serves as a site for triglyceride and cholesterol me-
tabolism, while the thyroid plays a role in hepatic lipid
homeostasis.
Moreover, diseases of thyroid, namely hypothyroidism
and hyperthyroidism, constitutes the most common
endocrine abnormality in recent years, diagnosed either
in subclinical or clinical form. According to a six-year
NHANES III Study, the prevalence of hypothyroidism
and hyperthyroidism in the population aged 12 and
older were 4.6% (0.3% clinical and 4.3% subclinical) and
1.3% (0.5% clinical and 0.7% subclinical), respectively
[11]. Risk factors associated with hypothyroidism are
clustered within metabolic syndrome and is also charac-
terized by insulin resistance [12]. The influence of high
dietary fat intake and the implications of a compromised
endocrine system may contribute to the risk of obesity,
metabolic syndrome and insulin resistance. Additionally,
there is evidence that hypothyroidism may directly affect
the liver structure or function. Hypothyroidism has been
associated in a few case reports with cholestatic jaundice
attributed to reduced bilirubin and bile excretion [13].
In experimental hypothyroidism, the activity of bilirubin
UDP glucuronyltransferase is decreased, resulting in a
reduction in bilirubin excretion [14]. Thyroid hormones
(THs) also oppose the action of insulin and stimulate
hepatic gluconeogenesis and glycogenolysis; they up-
regulate the expression of genes such as glucose trans-
porter type-4 (GLUT–4) and phosphoglycerate kinase,
involved in glucose transport and glycolysis, respectively,
thus acting synergistically with insulin facilitating glu-
cose disposal and utilization in peripheral tissues [15].
The liver is the second largest organ in the body and
plays a central role in the maintenance of systemic lipid
homeostasis. It serves multiple functions including me-
tabolism of lipids and carbohydrates, hormone produc-
tion, synthesis of clotting factors, and detoxification
[16,17]. The morphology of liver, as well as many organs,
is directly related to its function [18,19]. Substantial dis-
ruption in its anatomy or function may result in the se-
vere alteration of its metabolic roles, which may
adversely affect physiological functions. The most com-
mon abnormality in liver function tests is a two-to
threefold elevation in the alanine aminotransferase
(ALT) and aspartate aminotransferase (AST) levels
(transaminases). They are associated with inflammation
and/or injury to liver cells, a condition known as hepato-
cellular liver injury. Damage to the liver typically resultsin a leak of AST and ALT into the bloodstream [20].
The AST/ALT ratio is usually < 1, which can help distin-
guish non alcoholic fatty liver disease (NAFLD) from
alcoholic-related liver disease. When it is > 1 in NAFLD,
it suggests an advanced fibrotic stage of disease. In a re-
cent large survey of 12,808 men, ALT-dominant liver
disorders were related to obesity, lack of physical exer-
cise, and hyperlipidemia, whereas AST-dominant liver dis-
orders were related to alcohol consumption and diabetes
mellitus [21]. A study which evaluated high fat/high choles-
terol diets resulted in increased liver weight, fat deposition,
inflammation, and fibrosis with increased plasma activity of
liver enzymes [22]. Unexplained aminotransferase elevation
has been strongly associated with adiposity and other fea-
tures of the metabolic syndrome [23]. Therefore, the object-
ive of this study was to evaluate and compare the
physiological changes in euthyroid and thyroid altered
animal model fed saturated and unsaturated high fat diets.
Results and discussion
Body weights, Body lengths, Feed intake
The average baseline body weight (d = 0) of animals in
all experimental groups ranged from 118 g to 125 g,
with no statistical differences among groups. The final
body weights (d = 58) of all euthyroid animals were
higher compared to the thyroid altered animals across
all treatment groups (Table 1). Fat percent had no im-
pact on weight gain; there were no differences between
25 and 37% soy diets and 25 and 37% lard diets in eu-
thyroid animals. It was expected that thyroid altered rats
would have significantly higher body weights than the
euthyroid animals, however the lower body weight seen
in thyroid altered animals may be explained by the influ-
ence of thyroid hormones. The thyroid gland plays a
critical role in the de novo synthesis of fatty acids and
the degradation of lipids and simultaneously influences
all major metabolic pathways in the body including
those associated with obesity and metabolic syndrome
[12]. Alternatively, thyroid dysfunction is often associ-
ated with low basal metabolic rate that can influence
weight gain. Thyroid hormones impact the metabolism
of carbohydrates and fats and influence the synthesis,
mobilization and degradation of fats, which is often
linked with increased lipoprotein and lipase activity [24].
Sprague Dawley rats have shown varied responses in
food intake and weight gain when exposed to high-fat
diet. Wang et al. [25] conducted a study where male
Sprague Dawley rats were fed high fat (40%) soy oil and
lard diets, and there were no significant differences in
final body weight, weight gain, and energy intake.
The body lengths (Table 2) of the thyroid altered ani-
mals was significantly lower than the euthyroid animals
(p < 0.05). A possible reason for this divergence may be
due to decreased thyroid function during the animal’s
Table 1 Final body weights (g) of euthyroid and thyroid altered animals (n = 100)
Diet Euthyroid Thyroid altered
Adaptation Final Adaptation Final
Control 120.68 ± 7.15 348.41 ± 22.06 a 121.64 ± 5.18 316.39 ± 17.50 b
Lard 25% 119.28 ± 4.70 375.42 ± 13.28 ac 119.23 ± 5.78 319.31 ± 17.90 b
Soy Oil 25% 124.92 ± 7.15 390.52 ± 29.99 ad 119.57 ± 6.46 308.48 ± 38.29 b
Lard 37% 118.85 ± 6.71 388.07 ± 20.27 ac 123.83 ± 8.43 322.48 ± 15.65 b
Soy Oil 37% 121.21 ± 7.02 396.43 ± 21.29 ad 123.13 ± 5.72 320.91 ± 24.17 b
*Means ± SD.
a, b Values within row with different superscript differ at P < 0.05.
c, d Values within column with different superscript at P < 0.05.
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(six weeks of age) of PTU treatment. The rapid growth
phase occurs between 8 and 14 weeks of age. This may
explain decreased body weight and body length, as the
growth period may have been interrupted. Thyroid hor-
mones are critical for normal bone growth and develop-
ment. Biochemical studies have shown that these
hormones can affect the expression of various bone
markers in serum, reflecting changes in both bone
formation and reabsorption, and increases alkaline phos-
phatase and osteocalcin in osteoblasts [26]. The epiphys-
eal growth plate is made of several key characteristics
including cartilaginous, bony, and fibrous components,
which act together to achieve longitudinal bone growth.
The epiphyseal growth plate is the target element for
longitudinal growth [27]. Christian and Trenton [28]
reported a study in which PTU was administered to
Long-Evans rats daily from birth until 30 days of age.
They reported impaired growth and reduced body
weights. Their results are in agreement with the present
study and support the conclusion that the administra-
tion of PTU contributed to decreased body weights,
organ weights and body lengths.
The feed consumption throughout the experiment was
lower (Table 3) in all thyroid altered rats when com-
pared to euthyroid rats (P < 0.05). This reduction in feed
consumption substantially contributed to the lower




Control 43.00 ± 1.52 b 40.72 ± 0.98 c
Lard 25% 43.78 ± 0.72 ab 40.29 ± 1.62 c
Soy oil 25% 44.26 ± 0.93 a 41.06 ± 1.12 c
Lard 37% 44.48 ± 0.80 a 40.70 ± 1.84 c
Soy oil 37% 44.64 ± 0.70 a 40.67 ± 0.84 c
*Means ± SD.
a, b, c Values across rows and within columns with difference superscript differ
at P < 0.05.et al. [29], suggested that the triiodothyronine (T3) hor-
mone plays a critical role in appetite control. PTU func-
tions to inhibit the mechanism of thyroid iodide
peroxidase (TPO), which is needed to produce the T3
hormone. The results in the present study would sup-
port the role of T3 contributing to appetite control, as
food intake among thyroid altered animals was signifi-
cantly lowered than euthyroid rats. The T3 values
(Table 4) revealed a trend of higher levels of T3 hor-
mone in all thyroid altered animals. There were signifi-
cant differences (P < 0.05) in the control group and the
25% lard group across the euthyroid and thyroid altered
animals from the remainder of the experimental groups.
The higher values may be attributed to feedback loop in-
hibition in which the hormone was not being utilized
[26]. Damage to thyroid glands was confirmed through
histopathological evaluation (data not shown). Further-
more feed intake was not influenced by the type or
amount of fat in the diets. It would appear that thyroid
status had a greater impact than dietary composition.
Lipid profile
The normal range of total cholesterol in rats is 20 –
92 mg/dL. The lipid profile (Table 5) revealed elevated
total cholesterol in the thyroid altered animals compared
to the euthyroid animals; however, there were no statis-
tical differences between the treatment groups. These re-
sults may be due to the impairment of the thyroid glandTable 3 Average feed consumption (g) of euthyroid and
thyroid altered animals n = 100
Diet Group
Euthyroid Thyroid altered
Control 1448 ± 21.75 a 1266 ± 72.15 b
Lard 25% 1431 ± 4.92 a 1138 ± 55.03 c
Soy oil 25% 1428 ± 13.26 a 1190 ± 89.15 c
Lard 37% 1419 ± 10.77 a 1126 ± 40.34 c
Soy oil 37% 1410 ± 19.20 a 1119 ± 53.15 c
*Means ± SD.
a, b, c Values within rows and columns with difference superscript differ
at P < 0.05.




Control 3.05 ± 1.49 cd 4.6 ± 1.59 ab
Lard 25% 5.74 ± 0.93 a 4.02 ± 1.70 bc
Soy oil 25% 0.84 ± 0.59 e 1.78 ± 1.01 de
Lard 37% 0.95 ± 0.91 e 1.68 ± 1.13 de
Soy oil 37% 1.68 ± 1.14 de 2.52 ± 1.32 d
*Means ± SD.
a, b, c, d, e Values across rows and within columns with different superscript
differ at P < 0.05.
Welch-White et al. Lipids in Health and Disease 2013, 12:100 Page 4 of 9
http://www.lipidworld.com/content/12/1/100necessary to metabolize cholesterol, and confirms the
effectiveness of the PTU treatment. High density lipo-
protein (HDL) values were higher in the control diet
groups. Triglyceride levels were not significantly differ-
ent between euthyroid and thyroid altered rats, regard-
less of diet (P < 0.05). Low density lipoprotein (LDL)
values were the highest among thyroid altered animals.
The liver serves as a major site for cholesterol and trigly-
ceride metabolism, and the thyroid hormones play an
integral part in hepatic lipid homeostasis. Thyroid
hormones increase the expression of LDL receptors
on the hepatocytes and increase the activity of lipid
lowering liver enzymes, resulting in a reduction in low
density lipoprotein levels [30]. Thyroid hormones also
increase the expression of apolipoprotein A1, a major
component of high density lipoprotein [13]. In rats,
thyroid hormones stimulate hepatic cholesterol biosyn-
thesis, decrease hepatic triglyceride secretion, increase
bile formation and excretion of cholesterol, and de-
crease intestinal cholesterol absorption. In the case of
hypothyroidism, an increase in plasma cholesterol con-
centration may be expected [31]. Estrany et al. [32]
reported that the consumption of a high fat diet
containing monounsaturated (46.7%) and saturated
(43.3%) fat decreased serum triacylglycerols and total





Control 87.2 ± 20.56 a 53.4 ± 16.89 ab 60.7 ± 15.11 a 45.9 ± 2
Lard 25% 90.9 ± 21.54 a 72.1 ± 17.71 a 57.8 ± 10.10 a 40.1 ± 1
Soy oil 25% 90.2 ± 13.24 a 50.2 ± 9.78 b 50.5 ± 11.64 a 29.9 ± 1
Lard 37% 84.3 ± 8.67 a 54.3 ± 14.71a b 58 ± 15.25 a 21.8 ±
Soy oil 37% 88.6 ± 14.89 a 39.9 ± 7.99 b 57.8 ± 22.08 a 37.2 ±
*Means ± SD.
a, b Total Cholesterol values across rows and within columns with difference supersc
a, b HDL values across rows and within columns with difference superscript differ at
a, b TG values across rows and within columns with difference superscript differ at P
a, b, c LDL values across rows and within columns with difference superscript differ acontrol diet containing 24.1% monounsaturated and
20.7% saturated fat, respectively. The findings of this
study also revealed variations in levels of total choles-
terol and triglyceride, although differences were not
significant among treatment groups. The HDL values
were higher in the experimental groups which con-
sumed diets high in monounsaturated fat (MUFA), yet
thyroid altered animals showed a trend of decreased
HDL values. Jenkins et al. [33] reported that a higher
intake of monounsaturated fat may raise high-density
lipoprotein (HDL) cholesterol which is consistent with
the findings of the present study.
Liver enzymes
Liver enzymes, AST and ALT were elevated across all
treatment groups (Table 6). The normal ranges of ALT
and AST are 17.5 – 30.2 U/L and 45.7 – 80.8 U/L, re-
spectively. ALT levels were highest among euthyroid rats
fed unsaturated fat diets compared to the control rats (p
< 0.05). The groups with the highest levels of AST con-
sumed the 25 and 37% soy diets. Subsequently, these
rats had the highest body weights. The elevation of these
liver enzymes values may be indicative of some liver im-
pairment, or possibly damage. Liver damage resulting
from underlying cellular death is often associated with
cholestasis, drug-induced injury and obesity [34]. The
liver and the thyroid gland are intricately connected in
lipid metabolism as well as in the maintenance of
homeostasis. The findings of this study revealed in-
creased ALT and AST values; this may suggest that the
role of dietary fat and thyroid status influence the levels
of these transaminases. Panchal et al. [22] evaluated high
fat/ high cholesterol diets, and reported increased liver
weight, fat deposition, inflammation, and fibrosis with
increased plasma activity of liver enzymes.
Histopathological evaluation of the liver
The results of the histopathological evaluation of livers





0.57 ab 92.3 ± 13.56 a 57.1 ±18.15 ab 54.6 ± 10.36 a 57.5 ± 33.03 a
5.54 abc 93.0 ± 24.99 a 56.4 ± 34.69 ab 61.1 ± 11.59 a 48.8 ± 25.85 abc
5.82 bc 88 ± 5.25 a 56.0 ± 13.71 ab 54.9 ± 16.61 a 24.2 ± 6.51 c
11.65 c 89.4 ± 7.72 a 47.2 ± 21.81b ab 65.2 ± 30.37 a 35.6 ± 14.53 bc
9.31 bc 89.6 ± 13.21 a 40.6 ± 16.49 b 51.9 ± 19.28 a 38.6 ± 19.23 abc
ript differ at P < 0.05.
P < 0.05.
< 0.05.
t P < 0.05.
Table 6 ALT and AST serum values in euthyroid and thyroid altered animals (n = 100)
Diet ALT AST
Euthyroid Thyroid alt Euthyroid Thyroid alt
Control 43.3 ± 24.73 ab 38.5 ± 38.50 b 151.6 ± 85.46 a 94.4 ± 47.99 a
Lard 25% 46.9 ± 13.20 ab 39.4 ± 5.70 ba 115.1 ± 69.18 a 112.3 ± 47.81 a
Soy oil 25% 51.5 ± 11.30 ab 46.9 ± 18.82 ba 148.7 ± 96.39 a 153.9 ± 102.30 a
Lard 37% 46.7 ± 9.06 a 48.11 ± 14.89 ba 128.6 ± 65.53 a 149.8 ± 105.54 a
Soy oil 37% 53.8 ± 12.72 a 48.4 ± 10.84 ba 143.9 ± 88.59 a 121.7 ± 62.99 a
*Means of Average Reading Values.
a, b ALT Values across rows within columns with difference superscript differ at P < 0.05.
a AST Values across rows and within columns with difference superscript differ at P < 0.05.
Welch-White et al. Lipids in Health and Disease 2013, 12:100 Page 5 of 9
http://www.lipidworld.com/content/12/1/100increased presence of hepatic stellate (ito) cells and vac-
uoles in the thyroid altered animal compared to the eu-
thyroid animals. The thyroid altered animals had an
occurrence of vacuoles of 60% or greater across all treat-
ment groups. Morphological changes were observed in
the 37% fat dietary groups, as well as in the thyroid al-
tered animals. Hepatic stellate (ito) cells are naturally oc-
curring lipid containing cells and play a key role in the
pathogenesis of hepatic fibrosis [35]. Fibrosis is the
essential pathophysiologic consequence of chronic liver
injury, and it represents the common underlying mech-
anism for hepatic insufficiency [36] Figure 1 and 2.
It is suggested that hepatic stellate (ito) cells play a key
role in hepatic fibrogenesis, regardless of the underlying
etiology [36]. A pathological grade of +2 or higher hep-
atic stellate (ito) cells denotes abnormality and may sug-
gest comprised lipid metabolism. Abnormal fat vacuoles
are indicators of increased intracellular lipid, which may
account for abnormal synthesis, utilization, and/or ex-
port of fat [37]. These vacuoles are not naturally occur-
ring and their presence may infer liver abnormality.
Non-alcoholic fatty liver disease (NAFLD) is a liver dis-
ease defined by both clinical (non-alcoholic) and histo-
pathological characteristics [21]. NAFLD ranges from
steatosis and hepatic insulin resistance to advanced fi-
brosis and cirrhosis. Currently, NAFLD is considered as
the hepatic manifestation of the metabolic syndrome,
triggered by mechanisms including inflammation, lipid
overload and oxidative stress in adipose tissue and liverTable 7 Summary incidence of abnormal
histopathological liver changesin euthyroid and thyroid
altered animals
Diet Euthyroid Thyroid altered
Ito cells (≥2+) Vacuoles Ito cells (≥2+) Vacuoles
Control 0% 20% 20% 80%
Lard 25% 0% 30% 50% 70%
Soy 25% 20% 30% 60% 80%
Lard 37% 10% 0% 50% 80%
Soy 37% 0% 20% 30% 60%[38]. Pagadala et al. [39] reported a higher prevalence of
hypothyroidism in patients with NAFLD compared to
controls. The histopathological results of this study re-
vealed that increased hepatic stellate (ito) cells and vacu-
oles may indicate precursors of the development of
NAFLD, which is currently under further evaluation.
Conclusion
The oral administration of PTU successfully induced
hypothyroidism. The results revealed that thyroid altered
animals had smaller bodies and decreased body weights.
The liver and the thyroid gland work intricately together
in lipid metabolism as well as maintain homeostasis.
Thyroid altered animals had a trend of higher choles-
terol compared to the euthyroid animals. ALT and AST
values were higher for the thyroid altered groups. This
may suggest that the role of dietary fat and thyroid sta-
tus influence the level of these transaminases. Addition-
ally there were increased occurrences of hepatic stellate
(ito) cells and vacuoles in the liver of thyroid altered an-
imals compared to the euthyroid animals, across all
treatment groups. Chemically induced hypothyroidism
negatively impacted fat metabolism and growth, which
contributed to increased lipid accumulation in the liver.
Methods
Chemicals
Propylythiouracil or PTU (6-propyl-2-thiouracil) was
obtained from Sigma Aldrich (St. Louis, MO). HDLC
kits were obtained from Abcam (AbCam Cambridge,
MA). Total cholesterol and triglycerides kits were
obtained Wako analyzing kits (Wako Chemicals USA,
Richmond, VA).
Animal diets
Diets were obtained from Purina Lab Diets/Test Diets
(Richmond, IN). The diets were designed to be isocaloric
and isonitrogenous. The saturated fat diets contained
lard, while unsaturated fat diets contained soy oil. The
USDA dietary guidelines recommend dietary fat of 25 to
30%, of daily energy intake were taken into consideration
Figure 1 Histopathological evaluation of liver in Rats fed Lard Based Diets. (A) Represents a normal liver with normal morphology from a
euthyroid animal which consumed a control diet. (B) Represents a normal liver with normal morphology from a thyroid altered animal which
consumed a control diet. (C) Represents a normal liver in a euthyroid animal with normal morphology, which consumed a 25% lard diet.
(D) Shows liver from a thyroid altered animal which consumed 25% lard diet. There is evidence of +1 ito cells and a hepatocyte with the
presence of two small cytoplasmic vacuoles. (E) Represents the liver from a euthyroid animal which consumed 37% lard diet that shows the
presence of 3 ito cells (+4) and multiple vacuoles (+3). (F) Represents the liver from a thyroid altered animal which consumed 37% lard diet that
shows the Presence of ito cells (+4) and vacuoles (+2).
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calories in the diets were 37% (lard and soy), 25% lard
and soy), and 12% (modified AIN93 which served as the
control). The fat levels in the diets represent high, mod-
erate and low.
Animals and Experimental design
One hundred, 30 – 35 day old male Sprague Dawley
rats, with a mean weight of 100 g were obtained from
Harlan Sprague Dawley Laboratories, Inc. (Indianapolis,
IN). The animals were housed two per stainless steel
cage (60 cm × 60 cm × 15 cm), quarantined for 7 -d (fedFigure 2 Histopathological evaluation of liver in Rats fed Soy Oil Diet
euthyroid animal which consumed a control diet. (B) Represents a normal
consumed a control diet. (C) Represents a liver in a euthyroid animal which
with a grade of (+2). (D) Shows liver from a thyroid altered animal which c
(E) Represents the liver from a euthyroid animal which consumed 37% soy
(F) Represents the liver from a thyroid altered animal which consumed 37%
small vacuoles (+4).rodent lab chow) and acclimatized to the respective diets
for 7-d, after arrival at the university’s, College of Veter-
inary Medicine Comparative Medicine Resource Center.
The room temperature was 21 ± 1 C with relative hu-
midity of 50 ± 5% and a light/dark cycle of 12 hours
(light 8:00 – 20:00). Ten animals were weighed and ran-
domly assigned to one of ten experimental groups (n =
100); (Figure 3). Euthyroid and thyroid altered animals
were pair fed one of the five diets (control , 25% lard, 25%
soy, 37% lard and 37% soy) for 8-weeks and had access to
water ad libitum throughout the duration of the study.
PTU was administered orally and continuously to fives. (A) Represents a normal liver with normal morphology from a
liver with normal morphology from a thyroid altered animal which
consumed a 25% soy diet and shows the presence of 2 ito cells,
onsumed 25% soy diet and displays the presence of 2 ito cells (+2).
diet and displays the presence of ito cells (+3) and vacuoles (+2).
soy diet that shows the displays the presence of 1 ito cells (+2) and
Experimental Design
Normal Animal(50)














Figure 3 Experimental groups and test diets. Five of the experimental groups were comprised of normal or euthyroid rats, and the remaining
five experimental groups contained thyroid altered animals. Each diet of the five diets were fed to a normal (euthyroid) group as well as a thyroid
altered group. Saturated fat diets contain lard as the fat source, while unsaturated diets contain soy oil.
Welch-White et al. Lipids in Health and Disease 2013, 12:100 Page 7 of 9
http://www.lipidworld.com/content/12/1/100experimental groups (n = 50) in the drinking water at
0.05% (w/v) for 6 weeks. Corn syrup was added to the
drinking water to increase palatability in the PTU- treated
groups, and as a control in the non-treated groups. PTU
inhibits the mechanism of thyroid iodide peroxidase
(TPO) resulting in a chemically-altered thyroid state the
models [40]. Feed consumption was measured daily and
the animals were weighed weekly. Body lengths were
measure at the conclusion of the study. The rats were
fasted overnight on the final day of the study, prior to eu-
thanasia from overexposure to CO2. All experimental pro-
cedures were conducted according to the approved
protocols and guidelines of the university’s Animal Care
and Use Committee.
Blood, tissue collection and Histopathology
Blood samples were collected via cardiac puncture, from
each animal, for serum (EDTA containing tube), plasma
(heparin containing tube) and whole blood analysis (BD
Diagnostics, Franklin Lakes, NJ). Liver tissues were
harvested for histopathological analyses. The right lobe
of the liver was excised and placed in a 10% neutral buff-
ered formaldehyde solution for further analysis. The tis-
sues were sectioned, embedded, mounted and stained
with hematoxylin and eosin. The liver tissues wereevaluated for the presence of accumulated fat and gen-
eral morphology. All slides were then evaluated and
graded by a veterinary pathologist. The animal carcasses
were disposed of by incineration at the Post-Mortem
Building at the university’s College of Veterinary
Medicine.
Lipid profiles
The plasma concentrations of HDL-C were measured
enzymatically using Abcam analyzing kits, as described
by manufacturer (AbCam Cambridge, MA) and total
cholesterol and triglycerides were enzymatically mea-
sured using Wako analyzing kits (Wako Chemicals
USA, Richmond, VA). Low density lipoprotein (LDL)
cholesterol was estimated indirectly with the Friedewald
equation.
Statistical methods
Data were analyzed using the GLM procedure (SAS
Inst. Inc., Cary, NC) to compare the ten treatment
combinations. When the omnibus F-test indicated stat-
istical significance (p < 0.05), the treatment means were
separated using Duncan’s New Multiple Range Test. In
addition, selected contrasts were used to determine the
statistical significance of the difference between groups
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contrasts were conducted among dietary fat levels and
thyroid status. Data are presented as means ± SD.
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